Primary thombophilia. Report of 93 cases and 12 asymptomatic relatives
dc.contributor.author | Srur, E | |
dc.contributor.author | Vargas, C | |
dc.contributor.author | Salas, S | |
dc.contributor.author | Parra, JA | |
dc.contributor.author | Bianchi, V | |
dc.contributor.author | Mezzano, D | |
dc.contributor.author | Munoz, B | |
dc.contributor.author | Vasquez, M | |
dc.contributor.author | Pacheco, E | |
dc.date.accessioned | 2024-01-10T13:16:38Z | |
dc.date.available | 2024-01-10T13:16:38Z | |
dc.date.issued | 2004 | |
dc.description.abstract | Background: Thrombophilia is defined as an altered hemostasis that predisposes to thrombosis. It can be primary when there is a family clustering of the disease or secondary, when it is associated to an acquired risk factor. Aim: to report clinical features in a series of patients with primary thrombophilia. Material and methods: Review of clinical records of patients with thrombotic episodes that lead to the suspicios of primary thrombophilia. Analysis of asymptomatic adult close relatives of these patients. Results: We repot 93 subjects (56 females, age range 14-77 years) with repeated episodes of thrombosis and a family history of thrombosis. Twenty four percent had protein C deficiency, 24% had antithrombin III deficiency, 18% had resistance to activated C protein by factor V Leiden, 10% had protein S deficiency, and 10% had the G20210 mutation of prothrombin gene. Among acquired defects studied simultaneously, 30% had lupus anticoagulent and 11% had hyperhomocysteinemia. Twenty four percent of cases had more than one thrombophilic risk factor. Among asymptomatic relatives, five had factor V Leiden, four had protein C deficiency and three had the G20210 mutation of prothrombin gene. Conclusions: Thrombophilia must be suspected in young subjects with thrombotic episode and a family history. the type of coagulation defect will determine prognosis, and the type of treatment (Rev Med Chile 2004; 132: 1466-73). | |
dc.format.extent | 8 páginas | |
dc.fuente.origen | WOS | |
dc.identifier.eissn | 0717-6163 | |
dc.identifier.issn | 0034-9887 | |
dc.identifier.pubmedid | MEDLINE:15743157 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/78600 | |
dc.identifier.wosid | WOS:000226878600003 | |
dc.information.autoruc | Medicina;Mezzano D;S/I;99455 | |
dc.issue.numero | 12 | |
dc.language.iso | es | |
dc.nota.acceso | Sin adjunto | |
dc.pagina.final | 1473 | |
dc.pagina.inicio | 1466 | |
dc.publisher | SOC MEDICA SANTIAGO | |
dc.revista | REVISTA MEDICA DE CHILE | |
dc.rights | registro bibliográfico | |
dc.subject | antitbrombin III deficiency | |
dc.subject | factor v leyden | |
dc.subject | thrombophilia | |
dc.subject | ACTIVATED PROTEIN-C | |
dc.subject | VENOUS THROMBOSIS | |
dc.subject | ANTITHROMBIN-III | |
dc.subject | FACTOR-V | |
dc.subject | THROMBOPHILIA | |
dc.subject | RESISTANCE | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.ods | 05 Gender Equality | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.subject.odspa | 05 Igualdad de género | |
dc.title | Primary thombophilia. Report of 93 cases and 12 asymptomatic relatives | |
dc.type | artículo | |
dc.volumen | 132 | |
sipa.codpersvinculados | 99455 | |
sipa.index | WOS | |
sipa.index | Scopus | |
sipa.trazabilidad | Carga SIPA;09-01-2024 |